144 related articles for article (PubMed ID: 8240186)
1. Post-kala-azar dermal leishmaniasis.
Ramesh V
Australas J Dermatol; 1993; 34(1):35. PubMed ID: 8240186
[No Abstract] [Full Text] [Related]
2. Hypopigmented post-kala-azar dermal leishmaniasis.
Ramesh V; Ramam M; Singh R; Salotra P
Int J Dermatol; 2008 Apr; 47(4):414-6. PubMed ID: 18377613
[No Abstract] [Full Text] [Related]
3. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P
J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036
[TBL] [Abstract][Full Text] [Related]
4. Atypical presentation of post-kala-azar dermal leishmaniasis.
Islam QT; Basher A
Lancet Infect Dis; 2017 Nov; 17(11):1218. PubMed ID: 29115271
[No Abstract] [Full Text] [Related]
5. Nested PCR assay for detection of Leishmania donovani in slit aspirates from post-kala-azar dermal Leishmaniasis Lesions.
Sreenivas G; Ansari NA; Kataria J; Salotra P
J Clin Microbiol; 2004 Apr; 42(4):1777-8. PubMed ID: 15071047
[TBL] [Abstract][Full Text] [Related]
6. Nerve involvement in Indian post kala-azar dermal leishmaniasis.
Khandpur S; Ramam M; Sharma VK; Salotra P; Singh MK; Malhotra A
Acta Derm Venereol; 2004; 84(3):245-6. PubMed ID: 15202852
[No Abstract] [Full Text] [Related]
7. Post-kala-azar dermal leishmaniasis mimicking leprosy: experience with 4 patients, with some unusual features in 1.
Dhar S; Kaur I; Dawn G; Sehgal S; Kumar B
Lepr Rev; 1995 Sep; 66(3):250-6. PubMed ID: 7500822
[TBL] [Abstract][Full Text] [Related]
8. L. (L.) chagasi in AIDS and visceral leishmaniasis (kala-azar) co-infection.
Roselino AM; Chociay MF; Costa RS; Machado AA; Figueiredo JF
Rev Inst Med Trop Sao Paulo; 2008; 50(4):251-4. PubMed ID: 18813767
[TBL] [Abstract][Full Text] [Related]
9. Detection and characterization of Leishmania in tissues of patients with post kala-azar dermal leishmaniasis using a specific monoclonal antibody.
Ismail A; Kharazmi A; Permin H; el Hassan AM
Trans R Soc Trop Med Hyg; 1997; 91(3):283-5. PubMed ID: 9231195
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing post-kala-azar dermal leishmaniasis from leprosy: experience in the Sudan.
el Hassan AM; Hashim FA; Abdullah M; Zijlstra EE; Ghalib HW
Lepr Rev; 1993 Mar; 64(1):53-9. PubMed ID: 8464317
[TBL] [Abstract][Full Text] [Related]
11. Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.
Lindoso JAL; Moreira CHV; Celeste BJ; Oyafuso LKM; Folegatti PM; Zijlstra EE
Rev Soc Bras Med Trop; 2018; 51(1):105-107. PubMed ID: 29513829
[TBL] [Abstract][Full Text] [Related]
12. Post-Kala-azar dermal leishmaniasis due to Leishmania donovani in Europe--case report.
Antunes J; da Costa JB; Guimarães M; Vaz-Pinto I; Soares-Almeida L; Filipe P
Int J Dermatol; 2013 Dec; 52(12):1584-6. PubMed ID: 24261735
[No Abstract] [Full Text] [Related]
13. Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review.
Trindade MA; Silva LL; Braz LM; Amato VS; Naafs B; Sotto MN
BMC Infect Dis; 2015 Nov; 15():543. PubMed ID: 26592919
[TBL] [Abstract][Full Text] [Related]
14. Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India.
Pandey K; Das VN; Singh D; Das S; Lal CS; Verma N; Bimal S; Topno RK; Siddiqui NA; Verma RB; Sinha PK; Das P
J Clin Microbiol; 2012 Apr; 50(4):1478-9. PubMed ID: 22278840
[TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity reaction over lesions of post-kala-azar dermal leishmaniasis mimicking type 1 reaction in leprosy.
Dhar S; Malakar S
Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):66-7. PubMed ID: 10407631
[No Abstract] [Full Text] [Related]
16. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
[TBL] [Abstract][Full Text] [Related]
17. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
Zijlstra EE
PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
[TBL] [Abstract][Full Text] [Related]
18. Verrucous papillomatous lesion of post-kala-azar dermal leishmaniasis: fine needle aspiration diagnosis of an unusual presentation.
Bhadani PP; Sen R; Singh RK
Acta Cytol; 2007; 51(2):252-4. PubMed ID: 17425218
[No Abstract] [Full Text] [Related]
19. Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis.
Hasnain G; Shomik MS; Ghosh P; Rashid MO; Hossain S; Hamano S; Mondal D
Am J Trop Med Hyg; 2016 Dec; 95(6):1383-1385. PubMed ID: 27672208
[TBL] [Abstract][Full Text] [Related]
20. Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions.
El Harith A; Chowdhury S; Al-Masum A; Semião-Santos S; Das PK; Akhter S; Vetter JC; Haq I
J Med Microbiol; 1996 Feb; 44(2):141-6. PubMed ID: 8642576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
